MX2022016267A - Personal lubricants comprising lambda-carrageenan. - Google Patents
Personal lubricants comprising lambda-carrageenan.Info
- Publication number
- MX2022016267A MX2022016267A MX2022016267A MX2022016267A MX2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A MX 2022016267 A MX2022016267 A MX 2022016267A
- Authority
- MX
- Mexico
- Prior art keywords
- carrageenan
- viruses
- lambda
- sexually
- personal lubricants
- Prior art date
Links
- 229940113118 carrageenan Drugs 0.000 title abstract 3
- 229920001525 carrageenan Polymers 0.000 title abstract 3
- 239000000679 carrageenan Substances 0.000 title abstract 3
- 239000000314 lubricant Substances 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 4
- 235000010418 carrageenan Nutrition 0.000 abstract 2
- 230000001050 lubricating effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 2
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000005461 lubrication Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A pourable, non-toxic lubricating composition containing lambda carrageenan as an antiviral agent, for protection from viruses, including but not limited to sexually-transmitted viruses and respiratory viruses, and methods of using the lubricating compositions as a non-oily, psuedoplastic lubrication product and administering the carrageenan for reducing the propagation of sexually- transmitted viruses, including HPV, during sexual activity.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2020/038991 WO2021262141A1 (en) | 2020-06-22 | 2020-06-22 | Personal lubricants comprising lambda-carrageenan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022016267A true MX2022016267A (en) | 2023-03-31 |
Family
ID=79281651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022016267A MX2022016267A (en) | 2020-06-22 | 2020-06-22 | Personal lubricants comprising lambda-carrageenan. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4167956A4 (en) |
| JP (1) | JP2023538798A (en) |
| KR (1) | KR20230042020A (en) |
| CN (1) | CN115942941A (en) |
| AU (1) | AU2020454698A1 (en) |
| BR (1) | BR112022026026A2 (en) |
| CA (1) | CA3183518A1 (en) |
| MX (1) | MX2022016267A (en) |
| WO (1) | WO2021262141A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050239742A1 (en) * | 2004-04-08 | 2005-10-27 | Vivus, Inc. | Carrageenan-based formulations and associated methods of use |
| KR20080070482A (en) * | 2007-05-31 | 2008-07-30 | (주)디딤바이오텍 | A lubricating composition comprising agents which induce the mucosal immunity and a preparation method thereof |
| US20110229446A1 (en) * | 2010-03-02 | 2011-09-22 | Roman Stephen B | Method and composition to relieve sexual discomfort and improve vaginal health |
| KR20140074281A (en) * | 2011-07-20 | 2014-06-17 | 패트릭 에프. 카이저 | Intravaginal devices for drug delivery |
| US20180369137A1 (en) * | 2017-06-27 | 2018-12-27 | Lifestyles Healthcare Pte. Ltd. | Natural Lubricant |
| WO2019217618A1 (en) * | 2018-05-10 | 2019-11-14 | Mario Elmen Tremblay | Lubricated substrates comprising lambda-carrageenan |
-
2020
- 2020-06-22 CN CN202080103325.6A patent/CN115942941A/en active Pending
- 2020-06-22 KR KR1020237002595A patent/KR20230042020A/en unknown
- 2020-06-22 WO PCT/US2020/038991 patent/WO2021262141A1/en active Application Filing
- 2020-06-22 BR BR112022026026A patent/BR112022026026A2/en unknown
- 2020-06-22 JP JP2022580078A patent/JP2023538798A/en active Pending
- 2020-06-22 EP EP20942177.5A patent/EP4167956A4/en active Pending
- 2020-06-22 CA CA3183518A patent/CA3183518A1/en active Pending
- 2020-06-22 AU AU2020454698A patent/AU2020454698A1/en active Pending
- 2020-06-22 MX MX2022016267A patent/MX2022016267A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023538798A (en) | 2023-09-12 |
| CN115942941A (en) | 2023-04-07 |
| EP4167956A1 (en) | 2023-04-26 |
| EP4167956A4 (en) | 2024-02-21 |
| AU2020454698A1 (en) | 2023-02-23 |
| KR20230042020A (en) | 2023-03-27 |
| BR112022026026A2 (en) | 2023-03-07 |
| CA3183518A1 (en) | 2021-12-30 |
| WO2021262141A1 (en) | 2021-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018000285A (en) | Stuffy nose deblocking composition having antiviral activity. | |
| EP4342539A3 (en) | Lubricated substrates comprising lambda-carrageenan | |
| WO2022035911A3 (en) | Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent | |
| MY175587A (en) | Fire extinguishing composition containing saccharide and saccharide derivative | |
| MX2018010788A (en) | Ophthalmological composition. | |
| MY161434A (en) | Ferrocene-based fire extinguishing composition | |
| NZ602510A (en) | Treatment of lupus nephritis using laquinimod | |
| NZ752822A (en) | Compositions and methods for joint health | |
| MX2009008259A (en) | Ingredient systems comprising trehalose, food products containing trehalose, and methods of making same. | |
| MX2020005942A (en) | Oral thin film with high active agent loading. | |
| MX2018002257A (en) | Hydrogenated polybutadienes useful as lubricant additives. | |
| MX2020008991A (en) | Methods for altering body composition. | |
| MX2021013901A (en) | Compositions and methods for treating cancer. | |
| SA521421170B1 (en) | Fireproof composition | |
| MX2022016267A (en) | Personal lubricants comprising lambda-carrageenan. | |
| EA201800266A1 (en) | ANTI-VIRUS PHARMACEUTICAL COMPOSITION | |
| MX2022001429A (en) | Formulations including dihydrohonokiol. | |
| MX2021005530A (en) | Non-lethal defensive fluid composition and pressurized delivery system. | |
| MX2021005119A (en) | Aerosolised formulation. | |
| MX2023007940A (en) | Water-based fire-extinguishing agent. | |
| MX2013002649A (en) | Therapeutic agent for pain. | |
| MX2021005390A (en) | Novel amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate. | |
| EP4305970A3 (en) | Meat analogs comprising thin flakes for food compositions | |
| MX2016008546A (en) | Keloid reduction using topical allantoin. | |
| TW200718807A (en) | Composition for preventing rust in metal, and rust preventive material for metal using the same |